Ep 91: Beyond Metrics: Reimagining Success in Academic Medicine with Dr Anavekar
Ep 91: Beyond Metrics: Reimagining Success in Academic Medicine with Dr Anavekar

Average (ratings)
No ratings
 
  Your rating

In the second part of our mini-series exploring the concept of value in academic medicine, Dr Ankur Kalra once again engages in a compelling discussion with Dr Nandan Anavekar. Dr Anavekar, a Professor of Medicine at Mayo Clinic College of Medicine and consultant for both the Cardiovascular and Radiology Departments at Mayo Clinic, also serves as the Program Director for the Adult Cardiovascular Diseases Fellowship program.

 

In this stimulating and thought-provoking episode, Dr Kalra and Dr Anavekar delve into the topic of measuring success in medicine. Dr Anavekar puts forward the argument that the ambiguous definition of academic achievement often results in damaging biases that have long-term repercussions on the medical field. As a program director, Dr Anavekar believes that the number of published articles should not be the only or most crucial criterion for evaluating early-career faculty. He argues that it's important to also consider the "distance travelled" by candidates.

Dr Kalra raises pertinent questions about the practical implications of this approach, and Dr Anavekar provides candid insights into his responsibilities. The conversation also sheds light on the "publish or perish" mentality and highlights the need to prioritize patient needs over the ideals of the experts treating them.

 

Can we move beyond binary thinking when it comes to measuring success in medicine? How does Dr Anavekar tackle research questions? What is the true essence of being "academic"?

 

Questions and comments can be sent to “podcast@radcliffe-group.com” and may be answered by Ankur in the next episode.
Guest: @nandananavekar, host: @AnkurKalraMD and produced by: @RadcliffeCARDIO.


Read MoreRead Less
Share
Up Next
Ep 92: Beyond Metrics (Part 3): Redefining Success Through a Student-Centric Approach with Dr. Nandan Anavekar
EP92 • May 15, 2023 • 41m 36s
In this inspiring conversation, Dr Anavekar and Dr Kalra discuss the education of postgraduate medical students and reflect on Dr Anavekar’s role as a Program Director. Dr Anavekar shares his motivations and the moral framework he uses to approach his responsibility towards his students.
Read More
All Episodes
High-Sensitivity Cardiac Troponin ACS
EP02 • Apr 23, 2020 • 29m 55s
Ankur is back with his second #AudioArticle! This week he spoke with Santiago Garcia from the Minneapolis Heart Institute about Santiago’s US Cardiology Review 13.1 article on the role of high-sensitivity cardiac troponin (hscTn) assays and their ability to rapidly rule in or rule out acute coronary syndrome (ACS) with improved sensitivity.



Chest pain is one of the most common reasons for an emergency room visit in the US, with almost 6 million ER visits annually, yet there is no consensus on how to compare the results from various hscTn assays. Tune in to hear Santiago outline the advantages and limitations of using hscTn as a standard biomarket to evaluate patients with suspected ACS in the ER.



Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.
Read More
01: Conduction Abnormalities After TAVR/TAVI With Chad Kliger
EP01 • Apr 23, 2020 • 27m 44s
In our first episode, Ankur explains his vision for and inspiration to start ‘Parallax’, and speaks with Chad Kliger from Lenox Hill Hospital in New York about conduction abnormalities after transcatheter aortic valve replacement (TAVR/TAVI), a review article published in US Cardiology Review 13.1 Ankur and Chad look at conduction abnormalities after TAVR/TAVI with a focus on basic conduction system anatomy in relation to the aortic valve, the mechanism, incidence, predisposing factors for occurrence, impact on mortality and finally, proposed treatment algorithms for management. Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.
Read More
EP 107: JACC: Advances - Leadership & the Future of Publishing with Dr Silversides
EP107 • Feb 12, 2024 • 43m 21s
Dive into the unique synergy between her clinical practice and editorial leadership as Dr Silversides shares her vision for the journal. Learn how she navigates diverse responsibilities, manages peer reviews, and ensures fair evaluation of the submitted manuscripts. Get insights into launching a journal, from adapting to the needs of the readership and editorial board selection to time management. Dr Silversides joins Dr Kalra in exploring the evolving landscape of academic publishing, discussing the challenges and opportunities presented by AI and other advancements.
Read More
EP 106: Transforming Health Systems Through Economics with Dr Alex Carter
EP106 • Jan 29, 2024 • 47m
The podcast embarks on an exploration of the program's three fundamental pillars: health economics, outcomes measurement, and management. Dr. Carter underscores the importance of efficiently allocating scarce resources, evaluating health system performance through population outcomes, and translating theoretical knowledge into practical application through leadership.
Read More
EP 105: The Year 2023 in Review with Dr Sukh Nijjer
EP105 • Dec 19, 2023 • 1h 3m 40s
Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.
Read More
EP 104: Caring for All Hearts: Disparities in Care with Dr Anuradha Lala
EP104 • Dec 04, 2023 • 44m 2s
In this thought-provoking episode, Dr Ankur Kalra is joined by Dr Anuradha Lala. They delve into the critical topic of disparities in care within the healthcare system from a cardiologist's point of view and explore actionable steps towards a more inclusive and fair healthcare landscape.

This series is supported by ZOLL and is intended for Health Care Professionals.
Read More
EP 103: CCS-AMI: New Classification for Acute Myocardial Infarction with Dr Kumar
EP103 • Oct 30, 2023 • 42m 43s
In this informative episode, Dr Kumar shares what led his team and the CCS to introduce a new classification scheme for acute MI. He discusses how research from the past 15 years highlighted the need to incorporate tissue changes resulting from acute myocardial infarction (MI) into clinical practice. Dr Kumar outlines the four stages of CCS-AMI, and we gain insight into how this novel classification scheme could impact bedside medicine.
Read More